Pharmaceutical innovation increasingly focuses not only on the active ingredient but also on how the medicine is delivered. Advanced drug-delivery technologies can address challenges involving bioavailability, dosing frequency, patient convenience, drug stability, targeted delivery, controlled release and administration route.
Advanced formulation development can include oral dissolving films, transdermal systems, specialty injectables, liposomal systems, nanoparticles, nanoemulsions and controlled-release technologies. The development objective is to select the appropriate delivery technology based on the molecule's physicochemical and therapeutic characteristics.
FTF Pharma describes capabilities in oral, topical and injectable formulation development, formulation upgrading, new dosage forms, new combinations and QbD implementation. The company also identifies formulation development for NCEs, bioavailability enhancement and technology transfer among its services.
Advanced drug delivery requires collaboration between formulation scientists, analytical teams, process engineers and regulatory experts. A strong development strategy begins by identifying the clinical and biopharmaceutical challenge and then selecting the appropriate technology platform.
